ArticleJournal for immunotherapy of cancer2025

NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC.

Jianqi Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.